- Jeffrey W. Bird, M.D., Ph.D.
Managing Director, Sutter Hill Ventures, Inc.
- Bruce C. Cozadd
Chairman and Chief Executive Officer, Jazz Pharmaceuticals plc
- David R. Hoffmann
Chief Executive Officer, Hoffmann Associates
- Wilfred E. Jaeger, M.D.
Partner, Three Arch Partners
- George G. C. Parker, Ph.D.
Dean Witter Distinguished Professor of Finance and Management,
Graduate School of Business,
Stanford University
- David R. Parkinson, M.D.
Venture Partner, New Enterprise Associates
- Harold E. Selick, Ph.D.
Chief Executive Officer, Threshold Pharmaceuticals, Inc.
 |
